This spring, PANLAR designated Mary K. Crow, MD, a Master of Rheumatology. She was honored for her career in research and work extending research opportunities to investigators in Latin America.
Search results for: hip OA
Rheumatologists Across Borders
The EULAR/ACR/APLAR Research Exchange Program is an opportunity to learn and exchange ideas within the rheumatology community internationally. Here the program’s most recent participants share their experiences & excitement.
ACR Urges Strong AI Safeguards in State Model Legislation
In comments to the National Association of Insurance Commissioners, the ACR outlined several recommendations for a proposed state model law addressing the use of artificial intelligence in the insurance industry.
CMS to Implement AI-Based Model to Streamline Prior Authorization
Last week, the Centers for Medicare & Medicaid Services (CMS) announced that it is implementing a new prior authorization model called the Wasteful and Inappropriate Services Reduction (WISeR) Model. This six-year model, starting on Jan. 1, 2026, aims to reduce fraud, waste and abuse in traditional Medicare by using technology-enabled processes for prior authorization and…
Doctoring Differently, Part 1
Dr. Samantha Shapiro recounts her enthusiastic and ambitious early career in rheumatology—a path that culminated in burnout and a brave choice with new opportunities.
ACR-Led Resolutions Supporting Research Funding, Biosimilars Access Advance at Annual AMA House of Delegates Meeting
An ACR-led resolution that calls for the protection of NIH funding and the ability to negotiate indirect costs will become AMA policy, along with several other resolutions supported by the ACR.
Impact of Travel Ban, J-1 Visa Interview Pause on Rheumatology
A temporary suspension of new interviews for J-1 visas and an ongoing travel ban preventing nationals of 12 countries from entering the U.S. are likely to have a range of impacts on graduate medical training, the rheumatology workforce and research collaborations.
Arkansas Leads the Nation with Landmark Pharmacy Benefit Manager Reform
Signed into law in April, the legislation will ban direct and indirect PBM ownership of pharmacies, effective Jan. 1, 2026. It addresses longstanding concerns about conflicts of interest, market consolidation and patient access created by vertically integrated PBM pharmacy models.
Summer 2025’s Awards, Appointments & Announcements in the World of Rheumatology
Sharad Lakhanpal, MBBS, MD, Receives India’s Highest Honor for Overseas Indians In early January, Sharad Lakhanpal, MBBS, MD, MACR, FACP, a rheumatologist at Rheumatology Associates in Dallas and past president of the ACR, was one of only three Indian-Americans to receive the 2025 Pravasi Bharatiya Samman Award (PBSA). The award is conferred every two years…
New Analysis Reveals More Potential Contributors to Takayasu Arteritis
Recent research led to development of a cumulative genetic risk score for Takayasu arteritis, identifying differing susceptibility between groups with different genetic ancestries.
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 332
- Next Page »